Congratulations to the WVU Clinical trials Research Unit (CTRU) and Dr. Adham Salkeni, WVU’s principal investigator for the NRG Oncology group, the largest clinical trials collaborative network in the United States. During the recent biannual meeting of the NRG, our CTRU was recognized as among the top ten main member sites to enroll the most patients on cancer clinical trials between January and June 2017. “This places WVU on the national map for clinical trials accrual,” Salkeni said. “This shows that we offer state-of-the-art research studies that examine the role of targeted therapies for the treatment of a wide variety of cancers that affect our patient population.”
WVU professor of Occupational and Environmental Health Sciences recently spoke with Public News Service about the cancellation of a study investigating the health impacts of mountaintop removal and other surface mining. Read the full story online.
Cervical cancer can be insidious. Changes to the cervix are often detected with a pap smear, but for those with limited access to health care, cervical and vaginal cancers can go unnoticed for years—silently growing, spreading and invading other organs—and by the time they’re detected, they may be so advanced that the patient’s prognosis is poor and her treatment options few. Valerie Galvan Turner, a gynecologic oncologist at the West Virginia University Cancer Institute, has opened a randomized clinical trial to assess whether a novel supplemental treatment can help chemotherapy and radiation fight these dangerous forms of cancer better.